DUBLIN, IRELAND--(MARKET WIRE)--Aug 9, 2007 -- Trinity Biotech plc (NasdaqGS:TRIB - News) (DUBLIN: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2007.
